← All organizations

Carbylan Therapeutics, Inc.

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 1, 2014

Acquired by KalVista Pharmaceuticals, Ltd. → Merck on Nov 21, 2016

Timeline

2000s

Jan 1, 2004
Carbylan Therapeutics, Inc.— Founded

2010s

Nov 21, 2016
KalVista Pharmaceuticals, Ltd.— Acquired By
Oct 10, 2017
Merck— Now

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

triamcinolone

Indications

Studied for

Recent trials (1)

NCT02022930Lead sponsorPhase 3Jan 1, 2014

Details

Founded: Palo Alto, CA, US Jan 1, 2004
Last known activity: Jan 1, 2014